Advertisement

Topics

Equaline 44-112 | Nasal Decongestant

12:43 EDT 24th July 2014 | BioPortfolio

Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.
adults and children
12 years and older 
take 2 tablets every 4 to 6 hours;
do not take more than 8 tablets in
24 hours 
children ages 6 to 12 years take 1 tablet every 4 to 6 hours;
do not take more than 4 tablets in
24 hours 
children under 6 years do not use this product in children
under 6 years of age 

@font-face { font-family: Cambria; } @page Section1 {size: 8.5in 11.0in; margin: 1.0in 1.25in 1.0in 1.25in; mso-header-margin: .5in; mso-footer-margin: .5in; mso-paper-source: 0; } P.MsoNormal { MARGIN: 0in 0in 0pt; FONT-FAMILY: "Times New Roman"; FONT-SIZE: 12pt; mso-style-parent: ""; mso-pagination: widow-orphan; mso-ascii-font-family: Helvetica; mso-fareast-font-family: Cambria; mso-hansi-font-family: Helvetica; mso-bidi-font-family: "Times New Roman" } LI.MsoNormal { MARGIN: 0in 0in 0pt; FONT-FAMILY: "Times New Roman"; FONT-SIZE: 12pt; mso-style-parent: ""; mso-pagination: widow-orphan; mso-ascii-font-family: Helvetica; mso-fareast-font-family: Cambria; mso-hansi-font-family: Helvetica; mso-bidi-font-family: "Times New Roman" } DIV.MsoNormal { MARGIN: 0in 0in 0pt; FONT-FAMILY: "Times New Roman"; FONT-SIZE: 12pt; mso-style-parent: ""; mso-pagination: widow-orphan; mso-ascii-font-family: Helvetica; mso-fareast-font-family: Cambria; mso-hansi-font-family: Helvetica; mso-bidi-font-family: "Times New Roman" } DIV.Section1 { page: Section1 }The product packaging shown below represents a sample of that currently in use.  Additional packaging may also be available.

equaline®

compare to Sudafed® Nasal

Decongestant active ingredient*

NDC 41163-112-08

non-drowsy • maximum strength

nasal

decongestant

pseudoephedrine HCl

relieves:

• nasal & sinus congestion

• sinus pressure

12 doses

2 pills/dose

24 tablets, 30 mg each

TAMPER EVIDENT: DO NOT USE IF CARTON IS OPENED OR IF BLISTER UNIT IS TORN, BROKEN OR SHOWS ANY SIGNS OF TAMPERING

50844     ORG031011208

DISTRIBUTED BY SUPERVALU INC.

EDEN PRAIRIE, MN 55344 USA

Manufacturer

SUPERVALU INC.

Active Ingredients

Source

Clinical Trials [1168 Associated Clinical Trials listed on BioPortfolio]

Non-interventional Study With Ectoin Containing and/or Decongesting Nasal Spray in Patients With Rhinosinusitis

The goal of this non-interventional study is to investigate the efficacy and tolerability of an Ectoin containing Rhinosinusitis Nasal Spray (SNS01). Within the study, SNS01 will be used e...

Non-interventional Study of Ectoin Nasal Douche (END01) in Patients With Acute Viral Rhinosinusitis

The goal of this non interventional study is to investigate the efficacy, tolerability and safety of the newly developed Ectoin Nasal Douche END01. Within the study, END01 will be used as ...

Pretreatment to Reduce Pain and Discomfort During Fiberoptic Nasal Pharyngoscopy and Laryngoscopy

Fiberoptic laryngoscopy (FOL) is one of the most common procedure done in an Ear Nose Throat (ENT) clinic. Topical anesthesia or decongestant or both have been used to improve patient comf...

Oxymetazoline Hydrochloride in Combination With Nasal Glucocorticosteroid for Perennial Allergic and Non-Allergic Rhinitis in Subjects With Persistent Nasal Congestion

Nasal glucocorticosteroids (GCS) are considered first-line therapy for both allergic and non-allergic rhinitis.1-3 Nasal congestion can persist despite maximum treatment with intranasal G...

Steady State Kinetics of l-Methamphetamine and Validation of Sensitivity of Dose Estimation

The intent of this study is to see if the rate that the body breaks down l-methamphetamine (l-MA) could be used as an accurate estimate for the rate that the body breaks down d-methampheta...

PubMed Articles [554 Associated PubMed Articles listed on BioPortfolio]

Ophthalmic adverse effects of nasal decongestants on an experimental rat model.

To investigate the potential effects of chronic exposure to a nasal decongestant and its excipients on ocular tissues using an experimental rat model.

Effects of decongestant addition to intranasal corticosteroid for chronic rhinitis: a systematic review and meta-analysis.

Intranasal corticosteroid (INCS) is the most efficacious medicine for treating chronic rhinitis. A decongestant and INCS combination (INCS-D) is considered for nasal congestion that is not improved by...

Pediatric Nasal Traumas: Contribution of Epidemiological Features to Detect the Distinction Between Nasal Fractures and Nasal Soft Tissue Injuries.

Nasal bone is prone to injury due of its prominent position on the face. Epidemiologic surveys are necessary to investigate nasal traumas. The aim of the present study is to examine the distribution o...

Pediatric Nasal Obstruction.

Nasal obstruction is one of the most common problems seen by pediatric otolaryngologists. Prompt treatment of nasal obstruction can be critical in newborns and infants because of their obligatory nasa...

Does using a nasal barrier dressing prevent nasal injury in premature infants receiving nasal continuous positive airway pressure?

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...


Drugs and Medication Quicklinks


Searches Linking to this Drug Record